ICATIBANT 30 mg/3mL
ICATIBANT · INJECTION · Cipla USA Inc.
No Recall HistoryCurrently in Shortage
Plain English
ICATIBANT is a injection containing icatibant at 30 mg/3mL, taken subcutaneous. Manufactured by Cipla USA Inc..
Key Facts
- Brand Name
- ICATIBANT
- Generic Name
- ICATIBANT
- NDC Code (Product)
69097-664- Manufacturer
- Cipla USA Inc.
- Strength
- 30 mg/3mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA212446
- Marketing Start
- 07/13/2020
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
hereditary angioedema931 reports
weight increased274 reports
drug ineffective260 reports
weight decreased259 reports
product dose omission issue249 reports
product use issue240 reports
malaise201 reports
headache197 reports
inappropriate schedule of product administration189 reports
covid-19171 reports
Frequently Asked Questions
What is ICATIBANT used for?
ICATIBANT contains ICATIBANT. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is ICATIBANT a controlled substance?
ICATIBANT is not classified as a controlled substance by the DEA.
What is the generic name for ICATIBANT?
The generic name for ICATIBANT is ICATIBANT. There are 8 other brand versions of ICATIBANT.
What is the NDC code for ICATIBANT 30 mg/3mL?
The NDC (National Drug Code) for ICATIBANT 30 mg/3mL is 69097-664, listed by Cipla USA Inc..